Stockscreener 앱 받기
8.98
0.67%
0.06
시간 외 거래:
8.98
전일 마감가:
$8.92
열려 있는:
$8.99
하루 거래량:
137.06K
Relative Volume:
0.39
시가총액:
$294.53M
수익:
$65.42M
순이익/손실:
$-32.96M
주가수익비율:
-7.0709
EPS:
-1.27
순현금흐름:
$-19.87M
1주 성능:
-0.11%
1개월 성능:
-13.32%
6개월 성능:
-31.55%
1년 성능:
+25.77%
1일 변동 폭
$8.6815
$9.09
1주일 범위
$8.465
$9.13
52주 변동 폭
$5.45
$18.98
뉴로페이스 Stock (NPCE) Company Profile
명칭
Neuropace Inc
전화
(650) 237-2700
주소
455 N. BERNARDO AVENUE, MOUNTAIN VIEW
NPCE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NPCE
Neuropace Inc
|
8.98 | 291.58M | 65.42M | -32.96M | -19.87M | -1.27 |
|
ABT
Abbott Laboratories
|
134.28 | 227.88B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.14 | 152.55B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
377.58 | 143.34B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.88 | 114.49B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.35 | 46.11B | 5.69B | 4.14B | 577.90M | 6.96 |
뉴로페이스 Stock (NPCE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-28 | 개시 | H.C. Wainwright | Buy |
| 2025-01-21 | 개시 | UBS | Buy |
| 2024-03-14 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-01-30 | 개시 | Leerink Partners | Outperform |
| 2023-11-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-08-24 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2023-02-22 | 개시 | Lake Street | Buy |
| 2022-04-06 | 개시 | Wolfe Research | Outperform |
| 2022-01-19 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-01-07 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2021-11-11 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-08-18 | 개시 | Robert W. Baird | Outperform |
| 2021-05-17 | 개시 | JP Morgan | Overweight |
| 2021-05-17 | 개시 | Morgan Stanley | Overweight |
| 2021-05-17 | 개시 | SVB Leerink | Outperform |
| 2021-05-17 | 개시 | Wells Fargo | Overweight |
모두보기
뉴로페이스 주식(NPCE)의 최신 뉴스
News impact scoring models applied to NeuroPace Inc.Swing Trade Timing with Daily Forecast - Newser
Technical signs of recovery in NeuroPace Inc.Free High Growth Low Risk Stock Selection - Newser
NeuroPace (NPCE) to Release Earnings on Tuesday - Defense World
NeuroPace (NPCE) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
Will NeuroPace Inc. bounce back from current supportInvestment Life Cycle Planning Summary - Newser
What earnings revisions data tells us about NeuroPace Inc.Equity Market Return Forecast Model Update - Newser
Bank of New York Mellon Corp Sells 1,437 Shares of NeuroPace, Inc. (NASDAQ:NPCE) - Defense World
Is NeuroPace Inc. the Top Chart Pick This WeekNews Based Entry Opportunity Alerts Detected - metal.it
How does NeuroPace Inc. compare to its industry peersTake advantage of unprecedented market momentum - Jammu Links News
What makes NeuroPace Inc. stock price move sharplyExceptional financial outcomes - Jammu Links News
How volatile is NeuroPace Inc. stock compared to the marketUnbelievable profit margins - Jammu Links News
Does NeuroPace Inc. stock perform well during market downturnsGame-changing returns - Jammu Links News
What are the latest earnings results for NeuroPace Inc.Rapid-fire capital growth - Jammu Links News
NeuroPace Inc. Stock Analysis and ForecastGet daily updates on promising stocks - Jammu Links News
What institutional investors are buying NeuroPace Inc. stockGet exclusive access to professional stock picks - Jammu Links News
Is NeuroPace Inc. a growth stock or a value stockFree Stock Market Trend Analysis - Jammu Links News
What are analysts’ price targets for NeuroPace Inc. in the next 12 monthsHigh-octane gains - Jammu Links News
What catalysts could drive NeuroPace Inc. stock higher in 2025Rapid-fire capital growth - Jammu Links News
Is NeuroPace Inc. stock overvalued or undervaluedGet expert insights on market-moving stocks - Jammu Links News
What drives NeuroPace Inc. stock priceBuild wealth with high-performing stocks - Jammu Links News
How does NeuroPace Inc. generate profit in a changing economyGet daily expert analysis for smarter investing - Jammu Links News
Published on: 2025-08-03 08:27:39 - Jammu Links News
Is it the right time to buy NeuroPace Inc. stockExplosive trading opportunities - Jammu Links News
What is the risk reward ratio of investing in NeuroPace Inc. stockGrow your wealth with proven stock picks - Jammu Links News
Essex Investment Management Co. LLC Acquires New Position in NeuroPace, Inc. (NASDAQ:NPCE) - MarketBeat
Trend Dashboard Flags NeuroPace Inc. As Potential Swing TradeEarly Entry Tips With Low Risk Zone Shared - beatles.ru
NeuroPace Commends CMS for Maintaining FY25 Reimbursement Structure for Epilepsy with Neurostimulator Cases - The Manila Times
NeuroPace: CMS Maintains Current MS-DRG Assignment for RNS System Procedures - AInvest
NeuroPace Welcomes CMS Decision to Maintain FY25 Reimbursement Structure for Epilepsy with Neurostimulator Cases - AInvest
Medicare Maintains Critical Coverage: NeuroPace Epilepsy Treatment Reimbursement Secured for 2025 - Stock Titan
NeuroPace ‘commends’ CMS for maintaining FY25 epilepsy reimbursement structure - TipRanks
How NeuroPace Inc. stock performs during market volatilityConservative Asset Allocation Risk Analysis - Newser
Published on: 2025-07-30 18:03:00 - metal.it
NeuroPace Inc. Earnings Report Breakdown: What Investors Should KnowPattern Alert With ROI Driven Strategy Shared - metal.it
Why NeuroPace Inc. stock attracts strong analyst attentionFast Return Equity Trade Forecast Points to Small Caps - beatles.ru
Legato Capital Management LLC Purchases Shares of 41,107 NeuroPace, Inc. (NASDAQ:NPCE) - MarketBeat
NeuroPace to Report Second Quarter 2025 Financial Results on August 12, 2025 - 富途牛牛
Medical Device Maker NeuroPace Sets Q2 Earnings Date: Key Updates Expected for Epilepsy Treatment Leader - Stock Titan
How Efficient Is NeuroPace Inc. at Controlling Operating CostsReal Trader Watchlist of Hot Stocks Released - metal.it
What risks could impact NeuroPace Inc. stock performanceEarnings Play Trade Plan With Alerts Shared - metal.it
How did NeuroPace's revenue and expenses trend in Q4 2024? - AInvest
Should I hold or sell NeuroPace Inc. stock in 2025Market Forecast Alerts Backed By Experts - Jammu Links News
What markets is NeuroPace Inc. expanding into Is JKHY stock a good long term investment optionBeginner Investor Planner For Fast Growth - Jammu Links News
When is NeuroPace Inc. stock expected to show significant growthAchieve rapid capital gains with smart investing - Jammu Links News
What is the dividend policy of NeuroPace Inc. stockGame-changing capital returns - Jammu Links News
뉴로페이스 (NPCE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.17%
자본화:
|
볼륨(24시간):